Kang Jiuhong, Zhang Yuntao, Chen Jie, Chen Haifeng, Lin Changjun, Wang Qin, Ou Yingxian
School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, China.
Toxicol Sci. 2003 Aug;74(2):279-86. doi: 10.1093/toxsci/kfg137. Epub 2003 May 28.
The carcinogenicity of specific insoluble nickel compounds is mainly due to their intracellular generation of Ni2+ ion and its suppression on gene transcription, while the inhibition of Ni2+ on histone acetylation plays an important role in the suppression or silencing of genes. Recent studies on Ni2+ and histone H4 acetylation suggest that Ni2+ inhibits the acetylation of histone H4 through binding with its N-terminal histidine-18. It is well known that bound Ni2+ readily produces reactive oxygen species (ROS) in vivo, a critical factor inversely related with the occurrence of resistance of mammalian cells to Ni2+. Thus, we tried to find the possible role of ROS in the induction of Ni2+ on histone acetylation in the present study. We found that a high concentration of Ni2+ (no less than 600 microM) caused a significant decrease of histone acetylation in human hepatoma cells. This inhibition was shown to result mainly from the influence of Ni2+ on the overall histone acetyltransferase (HAT) activity indicated by the histone acetylation assay with the presence of a specific histone deacetylase (HDAC) inhibitor, trichostatin A (TSA). The in vitro HAT and HDAC assays further confirmed this result. At the same time, we found that the exposure of hepatoma cells to Ni2+ generated ROS. Coadministration of hydrogen peroxide with Ni2+ generated more ROS and more histone acetylation inhibition. Addition of the antioxidants 2-mercaptoethanol (2-ME) at 2 mM or N-acetyl-cysteine (NAC) at 1 mM, with Ni2+ together, completely suppressed ROS generation and significantly diminished the induced histone hypoacetylation. The data presented here prove that the ROS generation plays a role in the inhibition of histone acetylation, and, hence, the gene suppression and carcinogenesis caused by Ni2+ exposure, providing a new door for us to continuously understand the mechanism of ROS in the carcinogenicity of Ni2+ and the resistance of mammalian cells to Ni2+.
特定不溶性镍化合物的致癌性主要归因于其在细胞内产生Ni2+离子以及对基因转录的抑制作用,而Ni2+对组蛋白乙酰化的抑制在基因的抑制或沉默中起着重要作用。最近关于Ni2+与组蛋白H4乙酰化的研究表明,Ni2+通过与组蛋白H4的N端组氨酸-18结合来抑制其乙酰化。众所周知,结合的Ni2+在体内容易产生活性氧(ROS),这是一个与哺乳动物细胞对Ni2+耐药性发生呈负相关的关键因素。因此,在本研究中我们试图探究ROS在Ni2+诱导组蛋白乙酰化过程中可能发挥的作用。我们发现高浓度的Ni2+(不少于600微摩尔)会导致人肝癌细胞中组蛋白乙酰化显著降低。在存在特异性组蛋白去乙酰化酶(HDAC)抑制剂曲古抑菌素A(TSA)的情况下,通过组蛋白乙酰化测定表明,这种抑制主要是由于Ni2+对整体组蛋白乙酰转移酶(HAT)活性的影响所致。体外HAT和HDAC测定进一步证实了这一结果。同时,我们发现肝癌细胞暴露于Ni2+会产生活性氧。过氧化氢与Ni2+共同作用会产生更多的活性氧以及更强的组蛋白乙酰化抑制作用。添加2毫摩尔的抗氧化剂2-巯基乙醇(2-ME)或1毫摩尔的N-乙酰半胱氨酸(NAC)与Ni2+一起,可完全抑制活性氧的产生,并显著减轻诱导的组蛋白低乙酰化。此处呈现的数据证明活性氧的产生在组蛋白乙酰化的抑制中发挥作用,进而在Ni2+暴露导致的基因抑制和致癌过程中发挥作用,为我们持续了解活性氧在Ni2+致癌性及哺乳动物细胞对Ni2+耐药性中的机制提供了新的思路。